NURO Analysis: $2.3B Raised
What is NURO?
NURO specializes in non-surgical neurotechnology, particularly through its NUOS and MENTIS product lines. The company has processed over 1 billion neurological data points and collaborates with 19 hospitals for implementations. With over 10 years of research and development, NURO's technology is available in 9 countries and has been deemed low risk for users.
Location
Waterloo Accelerator Centre, Waterloo, Ontario, Canada
Employees
1-10
Founded
2017
Product Features & Capabilities
- NUOS 3 communication system
- MENTIS product line
- neurological sensors
- user interfaces
- accessories
Use Cases
Assist ALS patients with communication; Support individuals with brain injuries; Aid Alzheimer's patients in memory and communication; Provide solutions for autism therapy; Help cerebral palsy patients interact effectively
How much NURO raised
Funding - $2.3B
Other Considerations
FDA cleared for late-stage ALS patients; Collaborated with 19 hospitals; Over 1 billion neurological data points processed; Available in 9 countries; Officially deemed low risk to users
See something that needs updating? Suggest edits to this profile.